94 related articles for article (PubMed ID: 23128060)
1. Tin-mesoporphyrin in the treatment of refractory hyperbilirubinemia due to Rh incompatibility.
Maisels MJ; Yang H
J Perinatol; 2012 Nov; 32(11):899-900. PubMed ID: 23128060
[TBL] [Abstract][Full Text] [Related]
2. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.
Kappas A; Drummond GS; Munson DP; Marshall JR
Pediatrics; 2001 Dec; 108(6):1374-7. PubMed ID: 11731664
[TBL] [Abstract][Full Text] [Related]
3. Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin.
Martinez JC; Garcia HO; Otheguy LE; Drummond GS; Kappas A
Pediatrics; 1999 Jan; 103(1):1-5. PubMed ID: 9917431
[TBL] [Abstract][Full Text] [Related]
4. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin.
Valaes T; Drummond GS; Kappas A
Pediatrics; 1998 May; 101(5):E1. PubMed ID: 9565434
[TBL] [Abstract][Full Text] [Related]
5. Tin-mesoporphyrin in the treatment of severe hyperbilirubinemia in a very-low-birth-weight infant.
Reddy P; Najundaswamy S; Mehta R; Petrova A; Hegyi T
J Perinatol; 2003 Sep; 23(6):507-8. PubMed ID: 13679941
[TBL] [Abstract][Full Text] [Related]
6. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin.
Valaes T; Petmezaki S; Henschke C; Drummond GS; Kappas A
Pediatrics; 1994 Jan; 93(1):1-11. PubMed ID: 8265301
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hyperbilirubinemia pharmacologic approach SnMP(tin-mesoporphyrin).
Martínez JC; García HO; Otheguy LE; Drummond GS; Kappas A
J Perinatol; 2001 Dec; 21 Suppl 1():S101-3; discussion S104-7. PubMed ID: 11803428
[No Abstract] [Full Text] [Related]
8. Tin-metalloporphyrins: an answer to neonatal jaundice?
Steffensrud S
Neonatal Netw; 1998 Aug; 17(5):11-7; quiz 18-9. PubMed ID: 9791442
[TBL] [Abstract][Full Text] [Related]
9. Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production, and phototherapy in controlling hyperbilirubinemia in term and near-term newborns.
Kappas A; Drummond GS; Henschke C; Valaes T
Pediatrics; 1995 Apr; 95(4):468-74. PubMed ID: 7700742
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of severe neonatal hyperbilirubinemia.
Drummond GS; Kappas A
Semin Perinatol; 2004 Oct; 28(5):365-8. PubMed ID: 15686268
[TBL] [Abstract][Full Text] [Related]
11. Stannsoporfin with phototherapy to treat hyperbilirubinemia in newborn hemolytic disease.
Rosenfeld WN; Hudak ML; Ruiz N; Gautam S;
J Perinatol; 2022 Jan; 42(1):110-115. PubMed ID: 34635771
[TBL] [Abstract][Full Text] [Related]
12. Tin-mesoporphyrin, a potent heme oxygenase inhibitor, for treatment of intracerebral hemorrhage: in vivo and in vitro studies.
Wagner KR; Hua Y; de Courten-Myers GM; Broderick JP; Nishimura RN; Lu SY; Dwyer BE
Cell Mol Biol (Noisy-le-grand); 2000 May; 46(3):597-608. PubMed ID: 10872746
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia.
Bhutani VK; Poland R; Meloy LD; Hegyi T; Fanaroff AA; Maisels MJ
J Perinatol; 2016 Jul; 36(7):533-9. PubMed ID: 26938918
[TBL] [Abstract][Full Text] [Related]
14. Sn-mesoporphyrin suppression of hyperbilirubinemia in EHBR/Eis rats, an animal model of Dubin-Johnson syndrome.
Drummond GS; Kappas A
Pharmacology; 1998 Mar; 56(3):158-64. PubMed ID: 9532616
[TBL] [Abstract][Full Text] [Related]
15. Suppression of bilirubin production in the Crigler-Najjar type I syndrome: studies with the heme oxygenase inhibitor tin-mesoporphyrin.
Galbraith RA; Drummond GS; Kappas A
Pediatrics; 1992 Feb; 89(2):175-82. PubMed ID: 1734381
[TBL] [Abstract][Full Text] [Related]
16. Congenital nonobstructive, nonhemolytic jaundice: effect of tin-mesoporphyrin.
Rubaltelli FF; Dario C; Zancan L
Pediatrics; 1995 Jun; 95(6):942-4. PubMed ID: 7761229
[No Abstract] [Full Text] [Related]
17. A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin.
Kappas A
Pediatrics; 2004 Jan; 113(1 Pt 1):119-23. PubMed ID: 14702459
[No Abstract] [Full Text] [Related]
18. Metalloporphyrins in the management of neonatal hyperbilirubinemia.
Stevenson DK; Wong RJ
Semin Fetal Neonatal Med; 2010 Jun; 15(3):164-8. PubMed ID: 20006567
[TBL] [Abstract][Full Text] [Related]
19. Targeted delivery of a heme oxygenase inhibitor with a lyophilized liposomal tin mesoporphyrin formulation.
Cannon JB; Martin C; Drummond GS; Kappas A
Pharm Res; 1993 May; 10(5):715-21. PubMed ID: 8321837
[TBL] [Abstract][Full Text] [Related]
20. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase- deficient newborns.
Kaplan M; Hammerman C
Pediatrics; 1999 Feb; 103(2):536-7. PubMed ID: 10026070
[No Abstract] [Full Text] [Related]
[Next] [New Search]
